Change in multiple sclerosis prevalence over time in Australia 2010–2017 utilising disease-modifying therapy prescription data

JA Campbell, S Simpson Jr, H Ahmad… - Multiple Sclerosis …, 2020 - journals.sagepub.com
Objective: Determine the prevalence of multiple sclerosis (MS) in Australia in 2017 using MS-
specific disease-modifying therapy (DMT) prescription data and estimate the change in …
被引用次数：62 相关文章

Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease-modifying therapy prescription data

JA Campbell, S Simpson Jr… - Multiple sclerosis …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective Determine the prevalence of multiple sclerosis (MS) in Australia in 2017 using MS-
specific disease-modifying therapy (DMT) prescription data and estimate the change in …
[PDF] academia.edu

[PDF][PDF] Change in multiple sclerosis prevalence over time in Australia 2010–2017 utilising disease-modifying therapy prescription data

JA Campbell, S Simpson Jr, H Ahmad… - Multiple Sclerosis …, 2019 - academia.edu
Objective: Determine the prevalence of multiple sclerosis (MS) in Australia in 2017 using MS-
specific disease-modifying therapy (DMT) prescription data and estimate the change in …

Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease-modifying therapy prescription data.

JA Campbell, S Simpson Jr, H Ahmad… - Multiple Sclerosis …, 2019 - europepmc.org
Objective Determine the prevalence of multiple sclerosis (MS) in Australia in 2017 using MS-
specific disease-modifying therapy (DMT) prescription data and estimate the change in …

Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease modifying therapy prescription data

J Campbell, S Simpson JR, H Ahmad, B Taylor… - 2020 - figshare.utas.edu.au
Objective: Determine the prevalence of multiple sclerosis (MS) in Australia in 2017 using MS-
specific disease-modifying therapy (DMT) prescription data and estimate the change in …

Change in multiple sclerosis prevalence over time in Australia 2010–2017 utilising disease-modifying therapy prescription data.

JA Campbell, S Simpson Jr, H Ahmad… - Multiple Sclerosis …, 2020 - search.ebscohost.com
Objective: Determine the prevalence of multiple sclerosis (MS) in Australia in 2017 using MS-
specific disease-modifying therapy (DMT) prescription data and estimate the change in …

Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease modifying therapy prescription data

J Campbell, S Simpson JR, H Ahmad, B Taylor… - 2020 - figshare.utas.edu.au
Objective: Determine the prevalence of multiple sclerosis (MS) in Australia in 2017 using MS-
specific disease-modifying therapy (DMT) prescription data and estimate the change in …